V-Lab
Ultragenyx Pharmaceutical Inc MF2-GARCH Volatility Analysis
Volatility prediction for Monday, July 27th, 2026
1 Day
54.38%
decreased by 2.26%
1 Week
55.67%
decreased by 0.97%
1 Month
57.02%
increased by 0.38%
Analysis last updated: Friday, July 24, 2026 at 10:01 PM UTC
News Impact Curve
How returns affect tomorrow's volatilityVolatility Forecast
How volatility evolves over timeParameter Estimates
Jan 31, 2014 to Jul 24, 2026Model Insight
This asset exhibits a strong leverage effect: volatility responds almost entirely to negative shocks. The ARCH response to positive shocks is negligible.
σ
MF2-GARCH Model
Tap to view equation
| Parameter | Value | t-statistic |
|---|---|---|
m window Rolling window length | 126 | |
α ARCH Response to squared shocks | 0.0253 | 2.56** |
β GARCH Volatility persistence | 0.6471 | 22.66*** |
γ leverage Additional response to negative shocks | 0.1158 | 9.05*** |
λ₁ tau intercept Baseline long-term coefficient | 4.9301 | 0.09 |
λ₂ forecast adj. Forecast performance sensitivity | 0.3022 | 0.10 |
λ₃ tau persistence Long-term factor persistence | 0.3184 | 0.04 |
Persistence:
0.730
Half-life:
2 days
Other Ultragenyx Pharmaceutical Inc Analyses
Other MF2-GARCH Analyses on Equities